Advertisement
Advertisement

ENTX

ENTX logo

Entera Bio Ltd. Ordinary Shares

1.30
USD
Sponsored
-0.07
-5.11%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.29

-0.01
-0.69%

Entera Bio Ltd. Ordinary Shares Profile

About

Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.

Info & Links

CEO

Miranda Toledano

Headquarters

KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR
JERUSALEM, L3 9112002, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.enterabio.com

Auditor

Kesselman & Kesselman

Share holders

44

Employees

22

Entera Bio Ltd. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

70.29M

Enterprise Value

55.41M

Enterprise Value/EBITDA(ttm)

-4.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

240.43

Price to Book(mrq)

4.03

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-1527.98%

Return on Equity(ttm)

-66.39%

Return on Invested Capital(ttm)

-72.66%

Return on Assets(ttm)

-57.77%

Income Statement

Revenue(ttm)

42.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.50M

Net Income Available to Common(ttm)

-11.44M

Diluted EPS(ttm)

-0.26

Share Statistics

Beta (5Y Monthly)

1.54

52-Week Change

-41.44%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

46.62M

Dividend Yield

0.00%

Float4

41.78M

% Held by Insiders

10.38%

% Held by Institutions

14.11%

Balance Sheet

Total Cash(mrq)

14.88M

Total Cash Per Share(mrq)

0.32

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.94%

Quick Ratio(mrq)

6.94%

Book Value Per Share(mrq)

0.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.16

Free Cash Flow(ytd)

-7.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement